PharmaHub · Pharma Value Chain · Middle East & Africa

Saudi Arabia Neurology Devices Market Size, Share Outlook, Growth Analysis Report and Forecast Trends 2026-2030

The Saudi Arabia neurology devices market encompasses diagnostic and therapeutic equipment used to treat neurological conditions such as epilepsy, stroke, Parkinson's disease, and traumatic brain injury. Valued at approximately $142 million in 2025, the market is expanding at a compound annual growth rate of about 5.91%, reflecting broader healthcare modernization efforts across the kingdom. Growth is primarily propelled by the Saudi Vision 2030 healthcare investment agenda, a rising burden of neurological disorders linked to lifestyle-related diseases, and an aging population with increasing demand for advanced neuroimaging and neurostimulation technologies.

Market size · 2025
$142 million
CAGR · 2025–2030
5.91%
Forecast · 2030
$189 million
Basis
Claight Analysis
Market size (USD)
Base year 2025
Official data · Claight AnalysisForecast
Market size and forecast are Claight Analysis, informed by public research.
Forecast
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2025 base: $142M2030 est: $189M
Read the full Saudi Arabia Neurology Devices Market report →

Market Overview

The Saudi Arabia neurology devices market covers a range of products including electroencephalography (EEG) and electromyography (EMG) systems, neuroimaging equipment such as MRI and CT scanners, neurovascular intervention devices, and neurostimulation implants. The market forms part of the broader Middle East and Africa medical devices sector, with Saudi Arabia representing one of the largest national healthcare markets in the region due to its population size and economic resources. Government healthcare spending, which has grown substantially in recent years, supports procurement of advanced neurological equipment across public hospitals and specialty medical centers throughout the kingdom.

  • Market valued at roughly $142 million in 2025, positioned within the MEA region's growing medical technology segment
  • Product scope spans diagnostic devices, imaging systems, and therapeutic implants for neurological conditions
  • Public sector hospitals and neurology specialty centers are the primary end users

Growth Drivers

Saudi Vision 2030 has prioritized healthcare infrastructure expansion, with significant budget allocations toward hospital upgrades, new medical city developments, and increased access to specialized care including neurology. The rising prevalence of non-communicable diseases such as diabetes, hypertension, and obesity has contributed to higher rates of stroke and other neurological disorders, creating sustained demand for diagnostic and interventional devices. Additionally, the kingdom's aging demographic and growing awareness of neurological health are driving earlier diagnosis and treatment adoption.

  • Vision 2030 healthcare privatization and infrastructure investments are accelerating equipment procurement
  • Increasing incidence of stroke, epilepsy, and neurodegenerative disorders linked to lifestyle and demographic shifts
  • Government initiatives to attract foreign direct investment in healthcare have expanded hospital capacity and technology adoption
Want a deeper cut on Saudi Arabia Neurology Devices Market? We build bespoke studies on request.
Connect to an analyst →

Segmentation and Regional Analysis

Within the Saudi market, neuroimaging devices represent the largest segment, supported by widespread MRI and CT deployment across tertiary hospitals. Neurovascular and neurointerventional devices are growing rapidly as stroke treatment protocols become more advanced, while EEG and monitoring systems see steady demand from epilepsy and sleep disorder centers. Compared to other MEA markets such as South Africa and the UAE, Saudi Arabia benefits from a larger domestic patient population and more centralized procurement through the Ministry of Health, though regional disparities in device availability persist between major cities like Riyadh and Jeddah and more remote provinces.

  • Neuroimaging equipment leads market share, followed by neurovascular intervention and neurodiagnostic devices
  • Riyadh and the Eastern Province account for a disproportionate share of neurology device installations
  • Public sector procurement dominates, with growing private hospital demand in major urban centers

Trends and Outlook

What are the recent trends and outlook?

Telemedicine and digital health integration are beginning to influence the neurology devices market, with remote EEG monitoring and digital imaging platforms gaining attention as Saudi Arabia expands its healthcare digitization programs. The gradual shift toward public-private partnerships under Vision 2030 is expected to diversify procurement channels and increase adoption of newer technologies in private hospital networks. Over the medium term, the market is likely to sustain its 5.91% growth trajectory as neurological disease burden continues to rise, healthcare access improves, and local manufacturing and assembly initiatives under Saudi industrial policy begin to take shape.

  • Digital health and remote neuro-monitoring technologies are emerging as complementary trends to traditional device sales
  • Public-private partnership models are expected to broaden market participation beyond Ministry of Health procurement
  • Localization incentives under Vision 2030 may gradually shift some device manufacturing and assembly to Saudi Arabia
Talk to a Claight analyst
Do you want to research Saudi Arabia Neurology Devices Market?

Get in touch and our analysts will be happy to help with custom market sizing, deeper segmentation, supplier detail or a bespoke study built for you.

Connect to an analyst →

Market size and forecast are Claight Analysis, informed by public research and industry data. Historical years before 2025 and all forecast years are Claight estimates at the stated CAGR. Retrieved 2026.